Table 1.

TACI-Fc induces apoptosis of primary myeloma cells



Myeloma cell number/culture well
Patient no.
Control
TACI-Fc
DEX
DEX + TACI-Fc
Anti-IL-6 MoAb
Anti-IL-6 MoAb + TACI-Fc
Anti-IL-6 MoAb + DEX
Anti-IL-6 MoAb + DEX + TACI-Fc
1   113 774   97 474   81 280   56 940   120 250   98 610   37 180   23 800  
2   69 960   37 884   28 980   16 168   42 560   31 740   15 752   9 550  
3   18 864   10 494   19 800   8 400   20 692   12 096   19 008   4 344  
4   34 768   30 380   30 608   14 084   16 226   16 434   7 872   5 265  
5   99 540   53 508   34 914   28 457   59 280   30 576   15 228   7 912  
6   171 000   154 400   158 420   107 100   160 056   130 764   112 624   52 920  
Median value
 
84 750
 
45 696
 
32 761
 
22 312
 
50 920
 
31 158
 
17 380
 
8 731
 


Myeloma cell number/culture well
Patient no.
Control
TACI-Fc
DEX
DEX + TACI-Fc
Anti-IL-6 MoAb
Anti-IL-6 MoAb + TACI-Fc
Anti-IL-6 MoAb + DEX
Anti-IL-6 MoAb + DEX + TACI-Fc
1   113 774   97 474   81 280   56 940   120 250   98 610   37 180   23 800  
2   69 960   37 884   28 980   16 168   42 560   31 740   15 752   9 550  
3   18 864   10 494   19 800   8 400   20 692   12 096   19 008   4 344  
4   34 768   30 380   30 608   14 084   16 226   16 434   7 872   5 265  
5   99 540   53 508   34 914   28 457   59 280   30 576   15 228   7 912  
6   171 000   154 400   158 420   107 100   160 056   130 764   112 624   52 920  
Median value
 
84 750
 
45 696
 
32 761
 
22 312
 
50 920
 
31 158
 
17 380
 
8 731
 

Mononuclear cells from tumor samples of 6 patients with MM were cultured for 4 days in the presence of IL-6 (1 ng/mL) with or without DEX (10−6 M), TACI-Fc (10 μg/mL), or B-E8 anti-IL-6 MoAb (10 μg/mL). At day 4 of culture, the cell count and viability were determined and the percentage of CD 138+ viable plasma cells was determined by flow cytometry.

or Create an Account

Close Modal
Close Modal